Location History:
- Cambridgeshire, GB (2014)
- Cambridge, GB (2003 - 2018)
Company Filing History:
Years Active: 2003-2018
Title: The Innovative Contributions of Chris Abell
Introduction
Chris Abell is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of biochemistry, holding a total of 8 patents. His work focuses on the identification and modulation of compounds that interact with biological systems, paving the way for advancements in drug development.
Latest Patents
One of his latest patents is titled "Selection by Compartmentalized Screening." This invention describes a method for identifying compounds that bind to a target component of a biochemical system or modulate its activity. The method involves compartmentalizing the compounds into microcapsules along with the target, ensuring that only a subset of the repertoire is represented in multiple copies within any one microcapsule. This innovative approach enables the screening of large repertoires of molecules, which can serve as leads for drug development.
Another notable patent is the "Method of Synthesis and Testing of Combinatorial Libraries Using Microcapsules." This patent outlines methods for synthesizing and identifying molecules that bind to a target component of a biological system or modulate its activity. These methods are crucial for advancing research in drug discovery.
Career Highlights
Chris Abell has worked with esteemed organizations such as the Medical Research Council and United Kingdom Research and Innovation. His career is marked by a commitment to advancing scientific knowledge and developing practical applications for his inventions.
Collaborations
Throughout his career, Chris has collaborated with notable colleagues, including Andrew David Griffiths and Florian Hollfelder. These collaborations have further enriched his research and contributed to the success of his innovative projects.
Conclusion
Chris Abell's contributions to the field of biochemistry through his patents and collaborations highlight his role as a leading inventor. His innovative methods for screening and synthesizing compounds are paving the way for future advancements in drug development.